Koers Perspective Therapeutics, Inc.
Aandelen
CATX
US46489V1044
Medische apparatuur, benodigdheden & distributie
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,69 USD | -0,59% | +15,75% | +320,40% |
09/04 | PERSPECTIVE THERAPEUTICS, INC. : B. Riley ontvangt een koopadvies | ZM |
01/04 | PERSPECTIVE THERAPEUTICS, INC. : Oppenheimer handhaaft koopadvies | ZM |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 998 mln. 933 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -48 mln. -44,87 mln. | Nettowinst (verlies) 2025 * | -56 mln. -52,35 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-18,8
x | K/w-verhouding 2025 * |
-14,7
x | Werknemers | 118 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 76,6% |
Recentste transcriptie over Perspective Therapeutics, Inc.
1 dag | -0,59% | ||
1 week | +15,75% | ||
Lopende maand | +42,02% | ||
1 maand | +33,07% | ||
3 maanden | +256,54% | ||
6 maanden | +499,29% | ||
Lopend jaar | +320,40% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Johan Spoor
CEO | Chief Executive Officer | 51 | 03-02-23 |
Mark Austin
DFI | Director of Finance/CFO | 37 | - |
Jonathan Hunt
DFI | Director of Finance/CFO | 57 | 03-02-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Heidi Henson
BRD | Director/Board Member | 58 | 01-06-23 |
Lori Woods
CHM | Chairman | 62 | 03-02-23 |
Director/Board Member | 58 | 03-02-23 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
24-04-24 | 1,69 | -0,59% | 6 370 560 |
23-04-24 | 1,7 | +11,11% | 6 552 861 |
22-04-24 | 1,53 | +2,00% | 5 517 631 |
19-04-24 | 1,5 | +2,04% | 3 206 303 |
18-04-24 | 1,47 | +2,80% | 5 058 358 |
uitgestelde koers Nyse, 24 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+320,40% | 998 mln. | |
-2,89% | 187 mld. | |
-2,43% | 108 mld. | |
-4,10% | 67,71 mld. | |
+11,10% | 53,07 mld. | |
+15,86% | 47,36 mld. | |
+6,01% | 39,73 mld. | |
+9,55% | 28,56 mld. | |
+1,85% | 26,55 mld. | |
+15,97% | 25,13 mld. |